Elevation Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
2,448
+457
+23% +$40K 0.07% 127
2026
Q1
$170K Sell
1,991
-166
-8% -$14.8K 0.06% 126
2025
Q4
$170K Buy
2,157
+225
+12% +$17.6K 0.06% 127
2025
Q3
$154K Sell
1,932
-648
-25% -$55.3K 0.06% 136
2025
Q2
$235K Hold
2,580
0.09% 103
2025
Q1
$242K Hold
2,580
0.1% 100
2024
Q4
$235K Hold
2,580
0.1% 104
2024
Q3
$268K Hold
2,580
0.12% 96
2024
Q2
$250K Sell
2,580
-500
-16% -$46.1K 0.12% 96
2024
Q1
$277K Hold
3,080
0.14% 93
2023
Q4
$219K Buy
+3,080
New +$232K 0.13% 93
2023
Q3
Hold
0
342
2023
Q2
Hold
0
351

Other funds holding CL

Elevation Wealth Partners's CL Position: Q2 2026 in Review

Elevation Wealth Partners increased its Colgate-Palmolive (CL) stake by 23% in Q2 2026, buying an estimated $40K and bringing the position to 2,448 shares worth $224K. The position accounts for 0.07% of the portfolio, ranked #127.

Elevation Wealth Partners first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $277K in Q1 2024. 699 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Elevation Wealth Partners held 2,448 shares of Colgate-Palmolive worth $224K as of Q2 2026.
  • Elevation Wealth Partners bought 457 Colgate-Palmolive shares in Q2 2026, an estimated $40K.
  • Colgate-Palmolive made up 0.07% of Elevation Wealth Partners's portfolio in Q2 2026, its #127 holding.
  • Elevation Wealth Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Elevation Wealth Partners's Colgate-Palmolive position peaked at $277K in Q1 2024.
  • 699 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.